Pro Medicus Limited — Cyborg Score 8/10

Strong
Healthcare IT / Medical Imaging Software

Strategic Profile

The company is expanding its global footprint in enterprise imaging with growing presence in top U.S. hospitals and integrated delivery networks. Pro Medicus operates a scalable software-only model with rapid implementation methodology, significantly faster than industry norms. The company is expanding beyond radiology into cardiology and pathology on the same platform, a capability unique in the market.

Cyborg Score Rationale

Record revenue of $124.8M (28.4% YoY growth) and underlying EBIT growth of 29.7% to $90.7M demonstrate strong financial execution. The company signed over $280 million in new contracts including a $170 million, 10-year University of Colorado deal. Pro Medicus now serves 11 of the top 20 US hospitals including Mayo Clinic, Duke Health, and UCSF.

Top Insights

  • Stock trading at AUD 169.47 after 19.71% post-announcement decline from 52-week high of AUD 336, suggesting significant valuation reset
  • Underlying EBIT margin of 73% continues to expand despite reaching 70%+ levels previously deemed unsustainable
  • U.S. accounts for ~90% of revenue; seven new contracts valued at AUD 280 million demonstrate strong U.S. market traction
  • Company adopting bundled full-stack offerings; remains debt-free with increased cash despite buybacks and higher dividends

Named Competitors

  • Carestream PACS — Radiology IT and PACS solutions
  • Aidoc — AI-powered clinical workflow software
  • GE Healthcare PACS — Integrated healthcare IT systems
  • Philips IntelliSpace — Enterprise imaging and diagnostics

Recent Developments

  • (February 2026) Record HY26 results: 28.4% revenue growth to $124.8M and 230.9% NPAT jump (includes $150M unrealized 4DMedical gain)
  • (February 2026) Stock price declined 19.71% following earnings despite record results; closed at AUD 169.47
  • (February 2026) Signed seven new contracts totaling $280M+ including $170M, 10-year University of Colorado deal
  • (December 2025) Made $10M investment in 4D Medical Limited, generating $149.1M unrealized gains as of Dec 31

Open the full interactive Pro Medicus Limited report

Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.

Open report →